While the premarket approval process has been delegated by most of the competent authorities to the private sector, competent authorities have kept the responsibility for the surveillance of their market. Because of this situation, there is transfer of resource and energy to the monitoring of market including the vigilance system within each member state. The evaluation of incidents notified by the manufacturers and users represents a key source of information. Combined with sophisticated exchange of information between EU member states, and also with other countries like the U.S., Japan, Canada, or Australia, this provides a unique insight of the performance of devices in the post production phase.
EC Medical Devices Vigilance Systems and Post Marketing Surveillance
Jan 22nd, 2008Jan 23rd, 2008
London, --
GB
Latest in Home
LLMs rapidly evolving in nuclear medicine
October 24, 2025
Ghost scans problematic in POCUS trauma exams
October 24, 2025
PSMA-PET may require selective use to be cost-effective
October 24, 2025















